Peak Planning Group’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$877K Buy
3,487
+1
+0% +$215 0.2% 56
2026
Q1
$758K Sell
3,486
-179
-5% -$39.7K 0.21% 53
2025
Q4
$837K Buy
+3,665
New +$835K 0.23% 54
2025
Q2
Sell
-3,955
Closed -$829K 91
2025
Q1
$829K Buy
3,955
+20
+0.5% +$3.89K 0.35% 48
2024
Q4
$699K Sell
3,935
-328
-8% -$60.3K 0.29% 59
2024
Q3
$842K Sell
4,263
-84
-2% -$15.7K 0.37% 52
2024
Q2
$746K Buy
4,347
+325
+8% +$53.8K 0.37% 52
2024
Q1
$733K Sell
4,022
-8
-0.2% -$1.38K 0.46% 42
2023
Q4
$625K Sell
4,030
-1,263
-24% -$184K 0.45% 42
2023
Q3
$789K Sell
5,293
-539
-9% -$79.1K 0.62% 36
2023
Q2
$786K Sell
5,832
-628
-10% -$92.1K 0.58% 37
2023
Q1
$1.03M Buy
6,460
+273
+4% +$41.7K 0.84% 31
2022
Q4
$1,000K Buy
6,187
+1,263
+26% +$194K 0.88% 30
2022
Q3
$661K Buy
4,924
+644
+15% +$92.4K 0.61% 39
2022
Q2
$656K Buy
+4,280
New +$654K 0.55% 42
2021
Q4
$534K Buy
3,944
+164
+4% +$19.4K 0.39% 50
2021
Q3
$408K Buy
+3,780
New +$432K 0.35% 52
2021
Q1
$392K Sell
3,622
-214
-6% -$22.9K 0.38% 52
2020
Q4
$411K Buy
3,836
+13
+0.3% +$1.25K 0.47% 47
2020
Q3
$335K Buy
+3,823
New +$360K 0.47% 39

Other funds holding ABBV

Peak Planning Group's ABBV Position: Q2 2026 in Review

Peak Planning Group increased its AbbVie (ABBV) stake by 0.03% in Q2 2026, buying an estimated $215 and bringing the position to 3,487 shares worth $877K. The position accounts for 0.2% of the portfolio, ranked #56.

Peak Planning Group first reported a position in ABBV in Q3 2020 and has held it in 20 quarters since. The position peaked at $1.03M in Q1 2023. 4,206 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Peak Planning Group held 3,487 shares of AbbVie worth $877K as of Q2 2026.
  • Peak Planning Group bought 1 AbbVie share in Q2 2026, an estimated $215.
  • AbbVie made up 0.2% of Peak Planning Group's portfolio in Q2 2026, its #56 holding.
  • Peak Planning Group first reported a position in AbbVie in Q3 2020 and has held it in 20 quarters since.
  • Peak Planning Group's AbbVie position peaked at $1.03M in Q1 2023.
  • 4,206 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Peak Planning Group's 13F filing for Q2 2026, filed 12 Aug 2026.